Braskem (BAK) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.62
- Estimate
- -$3.59
- Surprise
- +145.2%
- Score today
- 5.5/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Braskem (BAK) beat the -$3.59 estimate with adjusted EPS of $1.62 — a large 145.2% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates BAK Hold at 5.5/10; no pre/post engine snapshot brackets this report.
1 of the last 4 quarters beat the estimate; this quarter's +145.2% surprise compares with a +2.2% four-quarter average. Next scheduled report: 2026-11-12.
What argues against it
- Market cap $264M below $400M minimum
- Momentum score 1.6/10 — below 4.5 minimum
- Death cross — 50-day MA below 200-day MA
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $1.11
- Price target
- $1.44
- Stop
- $1.03
- Upside to target
- +29.7%
- Reward-to-risk
- 2.0:1
Risk check: RSI 26 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
BAK at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Chemicals
- Market cap
- $264.4M
- P/E (fwd)
- -1.1
- 52-week range
- $0.92–$5.39
- Off 52-week high
- 79.4%
- RSI (14)
- 26
- Volume vs avg
- 0.36×
- Score today
- 5.5/10